hENT1 as a Predictive Biomarker in PDAC-Letter

Lenka N C Boyd; Mahsoem Ali; Jisce R Puik; Laura L Meijer; Tessa Y S Le Large; Hanneke W M van Laarhoven; Elisa Giovannetti; Geert Kazemier

doi:10.1158/1078-0432.CCR-22-3827

hENT1 as a Predictive Biomarker in PDAC-Letter

Clin Cancer Res. 2023 Aug 1;29(15):2944. doi: 10.1158/1078-0432.CCR-22-3827.

Authors

Lenka N C Boyd^#^{1

2

3}, Mahsoem Ali^#^{1

2

3}, Jisce R Puik^{1

2

3}, Laura L Meijer⁴, Tessa Y S Le Large^{1

2

3}, Hanneke W M van Laarhoven^{3

5}, Elisa Giovannetti^#^{2

3

6}, Geert Kazemier^#^{1

3}

Affiliations

¹ Amsterdam UMC, location Vrije Universiteit, Department of Surgery, Amsterdam, the Netherlands.
² Amsterdam UMC, location Vrije Universiteit, Department of Medical Oncology, Amsterdam, the Netherlands.
³ Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands.
⁴ Department of Surgery, Erasmus MC-University Medical Center, Rotterdam, the Netherlands.
⁵ Amsterdam UMC, location University of Amsterdam, Department of Medical Oncology, the Netherlands.
⁶ Cancer Pharmacology Lab, Fondazione Pisana per la Scienza, Pisa, Italy.

^# Contributed equally.

PMID: 37525961
DOI: 10.1158/1078-0432.CCR-22-3827

No abstract available

Grants and funding